“You have to be above reproach”: why doctors need to get better at managing their conflicts of interest

By Hole Ousia October 18, 2023

‘Preliminary’

Confirmed symposia for next year’s Summer Meeting of the British Association for Psychopharmacology [BAP] indicate an increasing defensiveness: BAP ‘symposia’ are generally sponsored by the pharmaceutical industry. BAP meetings continue … Continue reading ‘Preliminary’

By Hole Ousia September 11, 2023September 11, 2023

“Psychedelic drugs could soon treat alcoholism”

This article by Helen McArdle featured in the Herald on the 9th September 2023. Professor David Nutt, a career-long paid opinion leader for the pharmaceutical industry, is quoted and presents … Continue reading “Psychedelic drugs could soon treat alcoholism”